December 9, 2020
“ADMA Biologics (ADMA)… Are other analysts in agreement? They are. Only Buy ratings, 5, in fact, have been issued in the last three months, so the consensus rating is a Strong Buy. Given the $6.65 average price target, shares could… Continue Reading…
October 14, 2020
“Ferrari NV (RACE)… Overall, Ferrari stock has a Moderate Buy rating from the analyst consensus, with 11 reviews breaking down to 9 Buys, 1 Hold, and 1 Sell. The shares are selling for $184.48, and their $210.03 average price target suggests… Continue Reading…
Recent Comments